Skip to main content
VulnerabilityPublished

CVE-2026-123218: IBM Aspera Faspex · Incorrect Authorization

Affects IBM Aspera FaspexSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 9.8 Critical.

Data as of 7 Nov 2026, 04:04 UTC

CVSS 3.1 base score
9.8Critical
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (ibm)CVSS 3.19.8
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 7 Nov 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 6 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
IBMAspera FaspexAffected
  • >=5.0.0 <=5.0.19
Fixed in–

AI-suggested

Until an official fix is available, restrict access to IBM Aspera Faspex installations to trusted users only and monitor for suspicious activity related to privilege escalation attempts.

Description

IBM Aspera Faspex versions 5.0.0 through 5.0.19 contain an authorization vulnerability that allows an authorized user to bypass normal user restrictions and gain full administrative privileges. This flaw is classified as CWE-863 (Incorrect Authorization) and has a critical severity rating with a CVSS score of 9.8.

References

Community reviews

Loading reviews…